Dear reader of, please excuse the disruption. needs about $63500 in 2024. In 2023 we received donations of about $ 32200. Unfortunately, 99.8% of our readers do not donate. If everyone who reads this request makes a small contribution, our fundraising campaign for 2024 would be over after a few days. This donation request is displayed 23,000 times a week, but only 75 people donate. If you find useful, please take a minute and support with your donation. Thank you!

Since 01.06.2021 is supported by the non-profit ADxS e.V..

$18094 of $63500 - as of 2024-04-30
Header Image
Gender differences in ADHD


Gender differences in ADHD

ADHD in children is diagnosed significantly more frequently in boys than in girls. This difference levels out in adults.

While boys outside of clinics are diagnosed with ADHD 5 to 9 times more often than girls, only 3 times as many boys as girls are diagnosed in an inpatient clinical setting (probably due to the more detailed examination there).
In adults, the ADHD ratio is then balanced 1:1 in all environments.1

A large study found a gender ratio of 1.6:1 (boys to girls) in children with ADHD.2 While impulsivity was more common in boys and inattention in girls, hyperactivity was equally common.3

Whether the likelihood of individual symptoms occurring is gender-specific, so that women develop the ADHD-I subtype more frequently and the ADHD-HI subtype is more common in men, is now being questioned. One study found that boys and girls do not differ in the symptoms of inattention and hyperactivity.4 The distribution of symptoms also appears to be gender-independent in adults.5

1. Sex hormones as drivers of gender-specific mental disorders

Sex hormones (gonadal hormones, sex hormones, gonadal hormones):

  • Androgens (C19 steroid hormones), among others:
    • Testosterone
    • Androstenedione (biochemically reduced testosterone)
    • 5α- and 5β-dihyrotestosterone (DHT)
    • Dehydroepiandrosterone (DHEA).
  • Oestrogens (C18 steroid hormones)
    Like gestagens, oestrogens are female sex hormones. Oestrogens are C-18 steroid hormones. They are synthesized in the cells of the ovarian follicles in a cycle-dependent manner.
    There are four natural estrogens:
    • Estradiol (17β-estradiol, oestradiol; most bioactive oestrogen)
    • Estrone (3/10 of the bioactivity of estradiol)
    • Oestriol (1/10 of the bioactivity of estradiol)
    • Östetrol

Taking natural oestrogens orally is ineffective due to inactivation in the liver. Synthetic oestrogens are therefore used as medication and are primarily used to inhibit ovulation in hormonal contraception.

Other hormones can also have a psychopathological influence (e.g. gestagens (pregnancy hormones)).

Males are more prone to (externalizing) behavioural disorders in childhood (ADHD, ODD, CD, autism, learning disorders), whereas females are more prone to emotional (internalizing) disorders in adolescence (depression, anxiety disorders, dysthymia, eating disorders, PTSD). This could also be due to sex hormones.6789

The following explanations are largely based on the work of Martel et al (2013), who discussed the differentiating contribution of sex hormones in greater depth10

  • Testosterone may prenatally (“organizationally”) modulate dopaminergic circuits in the striatum, placing boys at greater risk for early development of inattention and disruptive behavior disorders.
    • An “extreme male brain” theory of autism views autism symptoms as exaggerations of typical sex differences and sees exposure to high prenatal testosterone levels as a risk factor for autism11
    • Testosterone appears to reduce men’s pain responses6
    • Androstenedione correlated with behavioral problems only in boys12
    • Testosterone-estradiol-binding globulin correlated negatively with sad affect and conspicuous behavior.12
  • Estradiol could modulate (“activating”) circuits in puberty, including in the amygdala (especially with effects on serotonergic signaling pathways), such that girls have a higher risk of internalizing and affective disorders
    • Lower prenatal testosterone levels are considered a risk factor for eating disorders1314 , while increasing estradiol levels during and after puberty reduce the risk1516

Sex hormones play an important role in the organization and plasticity of the brain and behavioral systems.1718

  • “Organizational” effects
    • Exposure to androgens
      • Androgens
      • Between pregnancy and 4 months of age
      • permanent masculinizing effects on the nervous system and behaviour
    • “Activating” effect
      • Predominantly estrogens
      • During adolescence
        • Puberty as a phenotypic activating event
          • Testosterone levels rise during puberty12
            • For men by a factor of 18
            • For women by a factor of 8
          • Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) stimulate the production of androgens, estrogen and progesterone19
          • Estradiol and testosterone can regulate gene expression and neurotransmission, e.g. GABA20 and serotonin21
          • Estradiol influences puberty22
            • Orbital cortex
            • MPFC
            • Amygdala23
            • Hippocampus23
          • Estradiol interacts with the HPA axis24
          • Estradiol enhances the stress response in the PFC in a sex-specific manner via serotonin, noradrenaline and dopamine24
          • Estrogen could interact with the HPA axis
            • Increase in the stress sensitivity of the HPA axis
            • Modulation of the HPA axis during puberty
              • Altered HPA activity can increase sensitivity to stress and thus susceptibility to depression24
            • Oestrogen is a strong regulator of several serotonergic systems (e.g. the 5HT2a receptor)2526
            • Rapidly changing oestrogen levels during puberty can directly influence the transcription of serotonin genes. Consequences:
              • Abnormalities in the amygdala
              • Low serotonin levels
      • Transient effect on neuronal structure and behavior
      • Change and activation of previously organized neuronal circuits
      • Possibly also some organizational effects9

1.1. Genetic sex, gonadal sex, hormonal sex

The genetic sex leads to a gonadal sex, which in turn is linked to the hormonal sex.10
The genetic (i.e. chromosomal) sex is determined at conception. Consequences are that a gene on the Y chromosome causes the gonads to develop into testes. The testes release several androgenic steroid hormones (e.g. testosterone), which masculinize the body and brain during pregnancy development.
Ovaries release little or no hormone prenatally. The relative absence of androgens causes the development of a female body and brain.
Hormonal sex is the circulating estrogen to androgen ratio, which is higher in most women than in men. Sexual differentiation (this refers to the development of humans (and animals) into males and females) is closely linked to the organizational effects of sex hormones.

1.2. Gender-specific differentiation of neuronal circuits and behavior

1.2.1. Theories

The following 3 theories are not mutually exclusive 2710 Classical theory
  • Androgens cause male development
  • lack of androgens causes female development
  • high testosterone levels (men) cause
    • “Upstream” effects
      • Increased cell proliferation
      • increased cell death in the right hemisphere of the brain
      • Slower prenatal development / slower brain development
        • resulting altered cerebral lateralization28
        • possible Consequences for Men:
          • more susceptible to environmental pollution
          • more variable behavioral results17
          • increased risk of learning disorders
          • increased risk of hyperactivity
          • prone to injuries and structural abnormalities in the left hemisphere for a prolonged period of time
      • increased neuronal lateralization (= specialization of the brain hemispheres)
        • Consequences include: after a focal stroke, women are more likely to regain speech than men29
      • Modulation of neurotransmission
      • Interaction with the genotype
    • “Downstream” effects
      • Influence on the selection of the environmental niche
      • Influence on the triggering of environmental reactions Active feminization

Ovarian hormones actively promote feminization of neuronal circuits and behaviour Gradient model

Influence hormones:

  • Behavioral differences between the sexes (e.g. in cognition, childhood play and aggression)
  • Behavioral variations within the sexes
    • Women who are prenatally exposed to higher androgen levels may exhibit more masculine traits (e.g. increased spatial abilities)

1.2.2. Sex hormones and dopamine

Pregnant rats subjected to forced stress had male offspring with reduced testosterone levels and increased dopamine levels in the striatum.30 Furthermore, testosterone levels can indirectly influence neuronal development through so-called “downstream” effects: via the selection of experiential niches by the organism and the triggering of environmental responses17

1.2.3. Sex hormones and sexually dimorphic brain structures, brain functions and behavior

Sex hormones influence the formation of brain structures and brain functions. This in turn influences behavior10

Larger for men:31

  • Total brain volume
  • White substance
  • Liquor
  • Cerebellum
  • Pons
  • Amygdala
    • medial amygdala nucleus10
  • Hypothalamus
  • Frontomedial cortex
  • Corpus callosum (unclear)32

Larger for women:31

  • Gray matter
    • in posterior, temporal and inferior parietal brain regions
      • larger share
      • greater cortical thickness
  • Hippocampus
  • Frontoorbital cortex
  • Upper frontal and lingual gyrus
  • front commissure10
  • Caudat (unclear)
  • Corpus callosum (unclear)

Other differences:

  • lower lateralization (i.e. specialization) of cortical functions in women
    • lower prevalence of left-handedness
  • greater variation in extracellular striatal dopamine across the estrous cycle in women33
  • Oestrogen and progesterone modulate dopamine in the striatum and nucleus accumbens only in women34
  • significantly higher juvenile increase in dopamine receptor density in the striatum, nucleus accumbens and prefrontal cortex in male rats (Andersen & Teicher, 2000).
  • global cerebral blood flow is higher in women31
  • Whole blood serotonin levels are higher in women31
  • Men synthesize serotonin faster31
  • higher availability of dopamine transporters in women31
  • higher presynaptic dopamine synthesis in the striatum in women31
  • IQ correlates with gray matter volume35
    • in men in the frontal and parietal lobe
    • in women in the frontal lobe and Broca’s area
  • emotional events are processed differently in the amygdala:36
    • Women: primarily in the left amygdala
    • Men: primarily in the right amygdala
    • This lateralization could be the reason why men tend to react physically to emotional stimuli, whereas women tend to think rather than act

1.3. Gender-specific susceptibility to neurotoxins

As described in the chapter Development (of ADHD) neurotoxins - especially prenatally and in childhood - are a significant risk factor for the development of ADHD.

The reasons given for the greater susceptibility of the male brain to neurotoxins are37

  • lower glutathione availability than in women
  • lower sulphate-based detoxification capacity than in women
  • Neurotoxins and testosterone show potentiating effects
  • stronger neuroinflammatory response in men
  • higher susceptibility to oxidative stress than women
  • lack of neuroprotective effects of female hormones (estrogen and progesterone), particularly with regard to the reduction of inflammation and oxidative stress

2. Theories about hormonal mechanisms of depression

2.1. Probability of depression increases in girls with puberty

Girls were only twice as likely to be depressed as boys from the age of 10 to 15. This 2:1 ratio was caused by altered estradiol and testosterone levels, but not by FSH and LH, was independent of Tanner stage, and persisted later in life.3839
A higher degree of negative affect correlated with higher testosterone levels, higher cortisol and lower adrenal hormones, but not with altered estradiol levels.40

2.2. Probability of depression and hormonal fluctuations in the menstrual cycle

Estradiol and progesterone levels are relatively low during menstruation. Estradiol levels rise during the follicular phase until the LH surge, when ovulation takes place. After ovulation, the estradiol level drops, while the progesterone level rises steadily. In the middle of the luteal phase, estradiol levels reach a second peak, but then both progesterone and estradiol decline throughout the premenstrual phase. At this point, menstrual bleeding begins and completes the cycle.41

The symptoms of depressive mood vary systematically with fluctuations in the menstrual cycle. In women, the likelihood of mood problems (i.e. depressed mood, apathy) is greatest in the mid to late luteal phase of the menstrual cycle. During this period, progesterone levels peak while estradiol levels drop. Negative affect is also cycle-dependent and occurs most strongly before or during the menstrual phase and less so in ovulatory or premenstrual phases10

Oral contraceptives changed the variability of mood over the course of the day. Triphasic preparations (oral contraceptives with three hormonal phases) caused increased affect variability.42 Depressed mood typically occurs during the premenstrual period when estradiol and progesterone decrease.43
In PMS, suppression of ovarian function by leuprolide improved the symptoms. However, in a subset, these recurred after replacement of estradiol or progesterone, suggesting an abnormal response to hormonal changes as a cause of PMS mood problems.44 In fact, women with premenstrual dysphoric disorder showed an abnormal gonadotropin response to estradiol exposure compared to other women:45

  • stronger negative feedback reaction up to the nadir LH level
  • higher LH levels at the nadir
  • more LH surge-like reactions
  • 50 % higher LH-AUC
  • LH response was associated with VAS-rated symptoms
  • the negative increment (AOC) correlated with flatulence in the luteal phase
  • AUC of LH correlated with irritability
  • Depressed mood correlated with
    • FSH basic mirrors
    • AUC of FSH during the negative feedback phase

2.3. Probability of depression and hormone fluctuations after childbirth / during menopause

15% of women develop symptoms of depression in the first six months after giving birth, when sex hormones drop rapidly and dramatically.10 A sharp drop in estradiol and progesterone after childbirth correlated with depression in women with a history of postpartum depression46

The onset of menopause is associated with a decrease in oestrogen levels and a 2-fold to 4.3-fold risk of irritability and depression,4748 49 while the risk of depression is reduced after menopause.
The risk of depression in women was5051

  • increased 2.5-fold during the menopause
  • decreased after the menopause
  • with a rapidly increasing profile of FSH decreases
  • with high levels and increased variability of FSH increased
  • with high levels and increased variability of LH increases
  • increases with rising estradiol levels and increased variability of estradiol

Estrogen administration during the menopause significantly reduced depressive mood.4152
Low estrogen levels or dramatic changes in estrogen levels appear to increase the risk of depression.

Whether estradiol administration after childbirth / during perimenopause / during menopause correlates with a reduction in depression is inconsistent. There are several studies for and against.10
Estradiol administration can accelerate the effect of antidepressants in non-responders in the menopause.53
Withdrawal of estradiol from rats exposed to high levels of estradiol and progesterone (to mimic levels during pregnancy) resulted in increased depressive symptoms.54 Estradiol administration increased mobility in rats, suggesting an antidepressant effect of estradiol administration.5556
An inverted-U curve may also be at work here: optimal estradiol levels are protective, reduced and increased estradiol levels increase depressive symptoms.
In order to investigate the relationship between estradiol levels and affect over a period of 30 or 60 days, daily measurements over the entire menstrual cycle are required.10

2.4. Estrogen appears to influence transcription and activity of serotonin genes

Oestrogen modulates the central neurotransmitter systems that play a role in depression, particularly that of serotonin 57 48 5859

2.5. Estrogens influence HPA activity

2.5.1. Estradiol influences HPA stress response

Estrogens, particularly estradiol, appear to enhance the stress response (i.e. the release of catecholamines) in the PFC.60 Estradiol does not appear to have antidepressant effects under stress conditions.61

Estrogen lowers the threshold for prefrontal cortical dysfunction resulting from stressful experiences.60
Estrogen, especially estradiol, thus increases the risk of depression by changing the thresholds for prefrontal activation in response to stress.

According to another view, estradiol is said to have a moderating effect on depression via interaction with stressful life events and the HPA axis. Estradiol moderates the function of the limbic-OPFC circuit and the HPA axis, which reduces the risk of depression.62 Estrogen significantly reduced the stress response of the HPA axis in postmenopausal women. The responses to ACTH, cortisol and noradrenaline were attenuated.63

The antidepressant effect of estradiol may also depend on optimal corticoid levels, suggesting an interaction between estradiol effects and HPA axis tone64

2.5.2. Progesterone enhances HPA stress response

The progestin progesterone appears to increase the stress response of the HPA axis in postmenopausal women. The responses to ACTH and cortisol were attenuated, while the response to noradrenaline was increased.63 Women with PMS did not show the normal increased response of the HPA axis to exercise during the luteal phase. Progesterone caused an increased HPA axis response to treadmill exercise testing in healthy controls. Estradiol did not cause an increased HPA response.65

3. Hormonal mechanisms of the development and modulation of ADHD

3.1. Sex hormones indirectly modulate the development of dopaminergic circuits

Sex hormones can modulate the processes that control the development of dopaminergic circuits and influence corresponding deficits in cognitive control and reward processes in ADHD.

High testosterone levels may affect dopaminergic neuronal circuitry by slowing overall neuronal development and leaving the dopaminergic components of the brain vulnerable for a prolonged period during prenatal development. Thus, prenatal testosterone levels could moderate the relationship between prenatal risk factors (including genes, pollutants, low birth weight, maternal smoking) and developing ADHD-related neurobiology.17

Polycystic ovary syndrome (PCOS) is associated with hyperandrogenemia, i.e. greatly increased androgen levels. PCOS during pregnancy increases the risk of ADHD by 95% in boys only.66
Women with PCOS had an increased risk of ADHD themselves, although no link was found between their testosterone levels and their ADHD symptoms68
More on this at Prenatal stressors as ADHD environmental causes In the chapter Development,

Maternal smoking increases the fetal testosterone level.69 Prenatal smoking causes a 1.9-fold70 to 2.7-fold risk of ADHD71 for the offspring. Other studies also found significantly increased risk values.72737475
More on this at Prenatal stressors as ADHD environmental causes In the chapter Development,

3.2. Sex hormones directly modulate the development of dopaminergic circuits

Masculinizing effects of sex hormones directly affect the prenatal development of dopaminergic neuronal circuits and dopamine function in

  • Nucleus accumbens
  • Striatum
  • PFC

and thus cause deficits in cognitive control and reward processes.
Androgen effects act on the striatum, including the caudate nucleus and the associated dopamine circuits.30

Animal studies using prenatal hormone manipulation in relation to ADHD are not yet known. There are only experiments with early childhood hormone manipulation. The transferability of the ADHD animal model of SHR with regard to gender differences in ADHD is questionable, as the animals do not show the gender differences in behavioral symptoms known in humans. Female SHR appear to be more impulsive than males, especially during estrus.76
SHR (spontaneously hypertensive rat) and Wistar (WKY) control animals were exposed to testosterone early in development (postnatal day 10). On postnatal day 45, SHR animals showed:77

  • additional deficits in spatial memory in the water maze (but not the WKY)
  • Indications of a dysfunctional HPA axis:
    • high basal ACTH values
    • low corticosterone levels
  • Suppression of tyrosine hydroxylase immunoreactivity in the frontal cortex
    The authors see this as support for the hypothesis that early androgen exposure can contribute to an increased expression of ADHD symptoms in the case of a genetic predisposition to ADHD.

High testosterone levels may increase the risk of ADHD symptoms through a maturational delay in the development of dopaminergic innervation and metabolism, as well as increased lateralization of underlying dopaminergic neuronal circuits and increased reuptake of dopamine neurotransmission.78
The Pavlovian conditioning of a visual stimulus paired with food was:79

  • weaker in female SHR than in male SHR
  • Wistar rats equal in both sexes
    A gonadectomy (castration) changed the Pavlovian conditioning:80
  • for male and female SHR: increased conditioning
  • for female Wistar rats: unchanged
  • in male Wistar rats: reduced conditioning

SHR showed increased motor activity when given androgens in early childhood. Wistar, on the other hand, showed no change.81

In male castrated SHR, testosterone increased the density of tyrosine hydroxylase-immunoreactive fibers (an indicator of innervation by catecholamines) in the frontal cortex more than in WKY. The authors see this as a possible explanation for the fact that high testosterone levels in adulthood do not increase ADHD symptoms in either SHR or men .82

These results suggest that dopaminergic neuronal circuits and cognition are hormonally influenced in SHR10
This also seems to affect ADHD symptoms.

Girls and boys with ADHD, on the other hand, show equally weak cognitive control.838485 Boys with ADHD-I showed less cognitive impairment than boys with ADHD-C and girls with ADHD-I or ADHD-C.86
So far, however, studies have always examined sex as a proxy, without investigating the direct effect of hormones themselves on cognitive control and reinforcement learning.

3.3. ADHD and externalizing symptoms correlate positively with prenatal testosterone exposure

Overall, the research findings on finger length ratios suggest that prenatal testosterone exposure is positively associated with ADHD symptoms and possibly also with related traits such as externalizing problems and sensation seeking. However, contrary to the conclusion of Martel et al10, we cannot conclude from the study that this is primarily the case for boys.

Several studies investigated the finger length ratio (and thus indirectly prenatal testosterone exposure) in clinically diagnosed samples of children with ADHD. These studies thus indirectly addressed the hypothesis that higher prenatal testosterone exposure is associated with increased ADHD symptoms. The results are indifferent - at least with regard to gender.

Increased prenatal testosterone exposure is (indirectly) indicated by a decreased ratio of index finger to ring finger length (index finger length divided by ring finger length, 2D:4D). A low 2D:4D ratio (i.e. high prenatal testosterone exposure) correlated in various studies with:

  • Hyperactivity
    • only for girls (preschool age)87
    • only in girls (preschool age), also impulsivity88
    • only in women (student age) on the left hand (also impulsivity)89
    • only in boys (school age), also behavioral problems90
    • independent of gender91
  • Impulsiveness92
  • Aggression
    • for adult men92
  • social problems
    • only for boys (school age)90
  • Sensation seeking (high testosterone levels at the same time)93
    • Sensation seeking shows gender differences in favor of boys and is associated with externalizing disorders.949510
  • ADHD
    • for adult men92
    • only in boys, most clearly in ADHD-I.96
    • in boys and girls (from 7 to 15 years) with ADHD-I (smaller CEOAEs and smaller 2D:4D) than in ADHD-C or controls97
    • for German men, but not for German women or Chinese men or women98
    • one study found no correlation between 2D:4D and ADHD symptoms or ADHD subtypes in children with ADHD.99
  • Inattention
    • independent of gender91
    • only in women, on the left hand (student age).89
    • Correlation low right 2D:4D / increased ADHD inattention symptomatology could be mediated by decreased conscientiousness.100
  • Alexithymia
    • for adult men92
  • Addiction
    • for adult men92

A high 2D:4D ratio (i.e. low prenatal testosterone exposure) correlated with

  • prosocial behavior
    • only for girls of school age90

Boys with autism/Asperger syndrome and ADHD/oppositional defiant disorder had lower finger length ratios than boys with anxiety disorders. Boys with autism spectrum disorders had lower finger length ratios than healthy controls101

A study using sibling sex distribution found evidence of increased intrauterine testosterone exposure in ADHD and ASD and reading impairment, which was significant only in reading impairment.102

3.4. ADHD and reduced prenatal / postnatal estrogen

Reduced prenatal and postnatal estrogen levels also appear to correlate with ADHD symptoms.
Women with Turner syndrome or a single X chromosome have ovaries that produce reduced prenatal and postnatal estrogen levels.103 These women also have a characteristic cognitive profile with largely ADHD-like deficits in:

  • visual-motor integration
  • Pattern recognition
  • Face recognition
  • motor speed
  • Coordination
  • Attention
  • Planning (Test of Attention Variables, Familiar Figures Test, Tower of Hanoi)
  • for legal-lateral, spatially demanding executive tasks104

A study of the menstrual cycle of regularly cycling young women found that decreased estradiol levels associated with increased progesterone or testosterone levels correlated with higher ADHD symptoms the next day, especially in women with high impulsivity. Phase analyses indicated an increase in ADHD symptoms both in the early follicular phase and in the early luteal phase or post-ovulation.105

3.4.1. Estrogen reduces COMT-mediated dopamine degradation in the PFC

Oestrogen genetically reduces the activity of the dopamine-degrading enzyme COMT 106 107108

The estrogen level in women is low after menstruation (day 1 - 9), then rises steadily to its maximum until ovulation (day 10 - 15), falls to 1/3 of the maximum with ovulation (day 16 / 17), then rises to 2/3 of the maximum by day 24 and then falls until menstruation (day 27).109

Shortly before ovulation and (slightly weaker) approx. 1 week after ovulation), dopamine degradation in the PFC is therefore significantly reduced (dopamine is increased, possibly reduced need for ADHD medication). Before menstruation, dopamine degradation is noticeably increased (dopamine is reduced, possibly increased need for ADHD medication)
COMT is therefore on average 30% less active in women than in men.110111
As COMT causes at least 60 % of dopamine degradation in the PFC (and a maximum of 15 % of dopamine degradation in the striatum112 ), women in the oestrogen-rich phase shortly before ovulation have almost 20 % less dopamine degradation in the PFC.

Consequences of this are that, with regard to PFC-mediated ADHD symptoms such as inattention, some women require a lower dosage of drugs with a dopaminergic effect in the PFC (such as stimulants or atomoxetine) during periods with high oestrogen levels (3 - 4 days before ovulation and approx. one week after ovulation) than during periods with low oestrogen levels.113 In individual cases, this depends on the COMT gene variant, among other things.
This could further explain the increased sensitivity of women compared to men, as a slightly higher dopamine level increases the intensity of perception.

Since the COMT Met-158-Met variant is also common in borderline, which causes five times slower dopamine degradation in the PFC, and estrogen further slows down COMT dopamine degradation, this connection could possibly provide a clue to explain the prevalence of borderline in women (75% of people with ADHD are women).114

The reduction in dopamine degradation in the PFC caused by estrogen via COMT means that (mild) stress can have different effects depending on gender.
In male humans and animals, the slightly increased dopamine level in the PFC during mild stress increases mental performance compared to the resting state. In female humans and animals, on the other hand, the slight increase in dopamine in the PFC due to mild stress (on average) leads to a deterioration in mental performance. This difference appears to be caused by oestrogen. The deterioration in mental performance due to mild stress only occurs in the estrogen-rich phase shortly before ovulation. In the estrogen-poor phase around menstruation, mild stress increases mental performance in women just as much as in men.11311560116117118119

3.4.2. Oestrogen increases oxytocin levels

As oestrogen increases oxytocin levels, all the effects of oxytocin are likely to be enhanced in women.


  • Reduces ACTH
  • Probably reduces CRH
  • Probably reduces stress symptoms mediated by the HPA axis
  • Increases the “tend and befriend” stress response
    • The combination of oxytocin and certain attachment patterns could be linked to the female “Tend and be Friend” stress response120121

Find out more at Oxytocin

3.4.3. Oestrogen reduces learning and memory problems

A high oestrogen level alleviates deficits in learning and memory.122
This could possibly explain why ADHD symptoms are often not yet detectable in girls during their school years and only become more apparent in women from the age of 35 (see “late onset ADHD” in women).

4. Different ADHD symptoms in boys and girls

Boys with ADHD have higher scores at123

  • Hyperactivity
  • Inattention
  • Impulsiveness
  • externalizing problems

Girls with ADHD showed higher scores at123

  • intellectual impairments
  • internalizing problems
    • e.g. far more frequent anxiety symptoms124

5. Development of symptoms over time by gender

While girls typically develop a large surge of increased symptoms in early adolescence, boys have an increased symptom manifestation from childhood onwards. For both sexes, early adolescence is associated with the risk of a significant increase in symptoms.125

6. Higher symptom intensity in diagnosed girls and women?

Girls with autism who also had ADHD showed significantly stronger symptoms of ADHD, learning disabilities and ODD than boys with ASD and ADHD in a large study.126

This is reminiscent of the increased symptom intensity of women who are diagnosed with ADHD as adults.

7. Higher divorce rate for women with ADHD

Women (in Japan) with ADHD seem to have even higher divorce rates than men with ADHD.127

8. More comorbidities in women with ADHD

Females (in Japan) with ADHD appear to have a higher rate of comorbidity than males with ADHD.127

9. No gender-specific differences in the social behavior of ADHD and ASD

A meta-analysis found no gender-specific differences in social and communication behavior in ADHD and ASD.128

10. COMT gene variant influences gender-specific perception of stress

Polymorphisms of the COMT gene primarily affect dopamine levels in the PFC and barely affect dopamine levels in other brain regions. Similarly, the noradrenaline level in the PFC is not influenced by COMT129

A distinction must be made:130

  • COMT-Val-158-Met (mixed Val/Met)
  • COMT-Val-158-Val (homozygous Val/Val)
  • COMT-Met-158-Met (homozygous Met/Met)

The COMT-Met-158-Met polymorphism causes 4 times slower dopamine degradation than the COMT-Val-158-Val variant.
COMT-Met-158-Met carriers are more suitable than COMT-Val-158-Val carriers131

  • Mentally more powerful (more efficient, not more intelligent)
  • Better executive functions of the PFC
  • More sensitive to stress (high dopamine level (only) in the PFC even at rest, significant increase in dopamine (only) in the PFC even under mild stress)132
    • As a result, the effect of amphetamine medication was probably worse (deterioration of working memory due to AMP under high stress)133. We suspect that the result may be transferable to MPH.
  • More anxious and
  • More sensitive to pain.

COMT is influenced by oestrogen. In women, the COMT-Val-158-Val polymorphism leads to better executive functions and better mental performance than the COMT-Met-158-Met polymorphism during periods of high oestrogen levels.134

11. Thyroid hormones in women as a masking factor of ADHD?

The updated European consensus on the treatment and diagnosis of ADHD in adults from 20181 points out the special role of thyroid hormones in the etiology of ADHD in women and girls.

Healthy 4-year-old children with thyroid-stimulating hormone levels in the upper normal range have a higher risk of ADHD than children with low free thyroxine levels. Thyroid disorders are more common in women than in men. As ADHD continues to show a possible association with thyroid hormone receptor insensitivity, a role of thyroid hormones in the development and manifestation of ADHD in women and girls should be further investigated.135

12. Creatine, choline, glutamate/glutamine in ACC and cerebellum

One study found significant sex- and age-specific differences in creatine, choline and glutamate/glutamine in the ACC, and significant age-specific differences in choline and glutamate/glutamine in the cerebellum.136

13. Differences in the effect of medication according to gender

ADHD medication seems to work slightly differently for women than for men.137
MPH showed

  • for girls:
    • reduced symptom severity and greater symptom improvement in the long term
    • a stronger effect of MPH at the beginning of the day, with an earlier decrease in effect
      • a single daily dose of MPH does not appear to be optimal for girls
  • for women:
    • less improvement in inattention, hyperactivity and impulsivity
      Non-stimulants showed
  • for girls and women
    • greater improvement in symptoms, hyperactivity, impulsivity and emotional dysregulation/emotional factors
    • ATX could be more helpful for girls and women with ADHD than for boys and men

  1. Kooij, Bijlenga, Salerno, Jaeschke, Bitter, Balázs, Thome, Dom, Kasper, Filipe, Stes, Mohr, Leppämäki, Brugué, Bobes, Mccarthy, Richarte, Philipsen, Pehlivanidis, Niemela, Styr, Semerci, Bolea-Alamanac, Edvinsson, Baeyens, Wynchank, Sobanski, Philipsen, McNicholas, Caci, Mihailescu, Manor, Dobrescu, Krause, Fayyad, Ramos-Quiroga, Foeken, Rad, Adamou, Ohlmeier, Fitzgerald, Gill, Lensing, Mukaddes, Brudkiewicz, Gustafsson, Tania, Oswald, Carpentier, De Rossi, Delorme, Simoska, Pallanti, Young, Bejerot, Lehtonen, Kustow, Müller-Sedgwick, Hirvikoski, Pironti, Ginsberg, Félegeházy, Garcia-Portilla, Asherson (2018): Updated European Consensus Statement on diagnosis and treatment of adult ADHD, European Psychiatrie, European Psychiatry 56 (2019) 14–34,, Seite 17

  2. Fayyad, Sampson, Hwang, Adamowski, Aguilar-Gaxiola, Al-Hamzawi, Andrade, Borges, de Girolamo, Florescu, Gureje, Haro, Hu, Karam, Lee, Navarro-Mateu, O’Neill, Pennell, Piazza, Posada-Villa, Ten Have, Torres, Xavier, Zaslavsky, Kessler; WHO World Mental Health Survey Collaborators (2017): The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys. Atten Defic Hyperact Disord. 2017 Mar;9(1):47-65. doi: 10.1007/s12402-016-0208-3.

  3. Slobodin, Davidovitch (2019): Gender Differences in Objective and Subjective Measures of ADHD Among Clinic-Referred Children. Front Hum Neurosci. 2019 Dec 13;13:441. doi: 10.3389/fnhum.2019.00441. eCollection 2019.

  4. Appelbaum, Lefering, Wolff, Tomasik, Ostermann (2019): Differential Item Functioning for Boys and Girls in a Screening Instrument for Attention Deficit Hyperactivity Disorder. Stud Health Technol Inform. 2019 Sep 3;267:3-8. doi: 10.3233/SHTI190797. n = 1449

  5. Biederman, Faraone, Monuteaux, Bober, Cadogen (2004): Gender effects on attention-deficit/hyperactivity disorder in adults, revisited. Biol Psychiatry. 2004 Apr 1;55(7):692-700.

  6. Holden C (2005): Sex and the suffering brain. Science. 2005 Jun 10;308(5728):1574. doi: 10.1126/science.308.5728.1574. PMID: 15947170.

  7. Arnold LE (1996): Sex differences in ADHD: conference summary. J Abnorm Child Psychol. 1996 Oct;24(5):555-69. doi: 10.1007/BF01670100. PMID: 8956084. REVIEW

  8. Miller, G. (2005): Sex and the Suffering Brain. Science, 308(5728), 1574–1577.

  9. Sisk CL, Zehr J (2005):. Pubertal hormones organize the adolescent brain and behavior. Front Neuroendocrinol. 2005 Oct-Dec;26(3-4):163-74. doi: 10.1016/j.yfrne.2005.10.003. PMID: 16309736.

  10. Martel MM, Klump K, Nigg JT, Breedlove SM, Sisk CL (2009): Potential hormonal mechanisms of attention-deficit/hyperactivity disorder and major depressive disorder: a new perspective. Horm Behav. 2009 Apr;55(4):465-79. doi: 10.1016/j.yhbeh.2009.02.004. PMID: 19265696; PMCID: PMC3616481.

  11. Knickmeyer RC, Baron-Cohen S (2006): Fetal testosterone and sex differences in typical social development and in autism. J Child Neurol. 2006 Oct;21(10):825-45. doi: 10.1177/08830738060210101601. PMID: 17005117. REVIEW

  12. Susman EJ, Inoff-Germain G, Nottelmann ED, Loriaux DL, Cutler GB Jr, Chrousos GP (1987): Hormones, emotional dispositions, and aggressive attributes in young adolescents. Child Dev. 1987 Aug;58(4):1114-34. PMID: 3608660.

  13. Culbert KM, Breedlove SM, Burt SA, Klump KL (2008): Prenatal hormone exposure and risk for eating disorders: a comparison of opposite-sex and same-sex twins. Arch Gen Psychiatry. 2008 Mar;65(3):329-36. doi: 10.1001/archgenpsychiatry.2007.47. PMID: 18316679; PMCID: PMC2883912.

  14. Klump KL, Gobrogge KL, Perkins PS, Thorne D, Sisk CL, Breedlove SM (2005): Preliminary evidence that gonadal hormones organize and activate disordered eating. Psychol Med. 2006 Apr;36(4):539-46. doi: 10.1017/S0033291705006653. PMID: 16336745.

  15. Klump KL, Perkins PS, Alexandra Burt S, McGue M, Iacono WG (2007): Puberty moderates genetic influences on disordered eating. Psychol Med. 2007 May;37(5):627-34. doi: 10.1017/S0033291707000189. PMID: 17335640.

  16. Klump KL, Keel PK, Culbert KM, Edler C (2008): Ovarian hormones and binge eating: exploring associations in community samples. Psychol Med. 2008 Dec;38(12):1749-57. doi: 10.1017/S0033291708002997. PMID: 18307829; PMCID: PMC2885896.

  17. Morris JA, Jordan CL, Breedlove SM (2004): Sexual differentiation of the vertebrate nervous system. Nat Neurosci. 2004 Oct;7(10):1034-9. doi: 10.1038/nn1325. PMID: 15452574.

  18. Phoenix CH, Goy RW, Gerall AA, Young WC (1959): Organizing action of prenatally administered testosterone propionate on the tissues mediating mating behavior in the female guinea pig. Endocrinology. 1959 Sep;65:369-82. doi: 10.1210/endo-65-3-369. PMID: 14432658.

  19. Sisk CL, Foster DL (2004): The neural basis of puberty and adolescence. Nat Neurosci. 2004 Oct;7(10):1040-7. doi: 10.1038/nn1326. PMID: 15452575. REVIEW

  20. Amin Z, Mason GF, Cavus I, Krystal JH, Rothman DL, Epperson CN (2006): The interaction of neuroactive steroids and GABA in the development of neuropsychiatric disorders in women. Pharmacol Biochem Behav. 2006 Aug;84(4):635-43. doi: 10.1016/j.pbb.2006.06.007. PMID: 16860856. REVIEW

  21. Rubinow DR, Schmidt PJ, Roca CA (1998): Estrogen-serotonin interactions: implications for affective regulation. Biol Psychiatry. 1998 Nov 1;44(9):839-50. doi: 10.1016/s0006-3223(98)00162-0. PMID: 9807639. REVIEW

  22. McEwen BS (2001): Invited review: Estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol (1985). 2001 Dec;91(6):2785-801. doi: 10.1152/jappl.2001.91.6.2785. PMID: 11717247. REVIEW

  23. Walf AA, Frye CA (2006): A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology. 2006 Jun;31(6):1097-111. doi: 10.1038/sj.npp.1301067. PMID: 16554740; PMCID: PMC3624621. REVIEW

  24. Shansky RM, Glavis-Bloom C, Lerman D, McRae P, Benson C, Miller K, Cosand L, Horvath TL, Arnsten AF (2004): Estrogen mediates sex differences in stress-induced prefrontal cortex dysfunction. Mol Psychiatry. 2004 May;9(5):531-8. doi: 10.1038/ PMID: 14569273.

  25. Andrade TG, Nakamuta JS, Avanzi V, Graeff FG (2005): Anxiolytic effect of estradiol in the median raphe nucleus mediated by 5-HT1A receptors. Behav Brain Res. 2005 Aug 30;163(1):18-25. doi: 10.1016/j.bbr.2005.04.015. PMID: 15951031.

  26. Birzniece V, Bäckström T, Johansson IM, Lindblad C, Lundgren P, Löfgren M, Olsson T, Ragagnin G, Taube M, Turkmen S, Wahlström G, Wang MD, Wihlbäck AC, Zhu D (2005): Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems. Brain Res Rev. 2006 Aug;51(2):212-39. doi: 10.1016/j.brainresrev.2005.11.001. PMID: 16368148. REVIEW

  27. Collaer ML, Hines M (1995): Human behavioral sex differences: a role for gonadal hormones during early development? Psychol Bull. 1995 Jul;118(1):55-107. doi: 10.1037/0033-2909.118.1.55. PMID: 7644606.

  28. McManus IC, Bryden MP (1991): Geschwind’s theory of cerebral lateralization: developing a formal, causal model. Psychol Bull. 1991 Sep;110(2):237-53. doi: 10.1037/0033-2909.110.2.237. PMID: 1946868.

  29. Yager JY, Wright S, Armstrong EA, Jahraus CM, Saucier DM (2005): A new model for determining the influence of age and sex on functional recovery following hypoxic-ischemic brain damage. Dev Neurosci. 2005 Mar-Aug;27(2-4):112-20. doi: 10.1159/000085982. PMID: 16046844.

  30. Gerardin DC, Pereira OC, Kempinas WG, Florio JC, Moreira EG, Bernardi MM. Sexual behavior, neuroendocrine, and neurochemical aspects in male rats exposed prenatally to stress. Physiol Behav. 2005 Jan 31;84(1):97-104. doi: 10.1016/j.physbeh.2004.10.014. PMID: 15642612.

  31. Cosgrove KP, Mazure CM, Staley JK (2007): Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry. 2007 Oct 15;62(8):847-55. doi: 10.1016/j.biopsych.2007.03.001. PMID: 17544382; PMCID: PMC2711771. REVIEW

  32. Allen JS, Damasio H, Grabowski TJ (2002): Normal neuroanatomical variation in the human brain: an MRI-volumetric study. Am J Phys Anthropol. 2002 Aug;118(4):341-58. doi: 10.1002/ajpa.10092. PMID: 12124914.

  33. Becker JB (1999): Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol Biochem Behav. 1999 Dec;64(4):803-12. doi: 10.1016/s0091-3057(99)00168-9. PMID: 10593204. REVIEW

  34. Xiao L, Becker JB (1994): Quantitative microdialysis determination of extracellular striatal dopamine concentration in male and female rats: effects of estrous cycle and gonadectomy. Neurosci Lett. 1994 Oct 24;180(2):155-8. doi: 10.1016/0304-3940(94)90510-x. PMID: 7700570.

  35. Haier RJ, Jung RE, Yeo RA, Head K, Alkire MT (2005): The neuroanatomy of general intelligence: sex matters. Neuroimage. 2005 Mar;25(1):320-7. doi: 10.1016/j.neuroimage.2004.11.019. PMID: 15734366.

  36. Rillich (2019): Das dopaminerge System im Gehirn des Menschen: molekulare Grundlagen, Anatomie, Physiologie und Pathologie

  37. Kern JK, Geier DA, Homme KG, King PG, Bjørklund G, Chirumbolo S, Geier MR (2017): Developmental neurotoxicants and the vulnerable male brain: a systematic review of suspected neurotoxicants that disproportionally affect males. Acta Neurobiol Exp (Wars). 2017;77(4):269-296. PMID: 29369294.

  38. Angold A, Costello EJ, Worthman CM (1998): Puberty and depression: the roles of age, pubertal status and pubertal timing. Psychol Med. 1998 Jan;28(1):51-61. doi: 10.1017/s003329179700593x. PMID: 9483683. n = 800

  39. Angold A, Costello EJ, Erkanli A, Worthman CM (1999): Pubertal changes in hormone levels and depression in girls. Psychol Med. 1999 Sep;29(5):1043-53. doi: 10.1017/s0033291799008946. PMID: 10576297. n = 800

  40. Susman EJ, Dorn LD, Chrousos GP (1991): Negative affect and hormone levels in young adolescents: Concurrent and predictive perspectives. J Youth Adolesc. 1991 Apr;20(2):167-90. doi: 10.1007/BF01537607. PMID: 24265005. n = 108

  41. Rosenfield RL (1991): Puberty and its disorders in girls. Endocrinol Metab Clin North Am. 1991 Mar;20(1):15-42. PMID: 2029884. REVIEW

  42. Oinonen KA, Mazmanian D (2001): Effects of oral contraceptives on daily self-ratings of positive and negative affect. J Psychosom Res. 2001 Nov;51(5):647-58. doi: 10.1016/s0022-3999(01)00240-9. PMID: 11728505. n = 96

  43. Sundström Poromaa I, Smith S, Gulinello M (2003): GABA receptors, progesterone and premenstrual dysphoric disorder. Arch Womens Ment Health. 2003 Feb;6(1):23-41. doi: 10.1007/s00737-002-0147-1. PMID: 12715262. REVIEW

  44. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR (1998): Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med. 1998 Jan 22;338(4):209-16. doi: 10.1056/NEJM199801223380401. PMID: 9435325. n = 35

  45. Eriksson O, Bäckström T, Stridsberg M, Hammarlund-Udenaes M, Naessén T (2006): Differential response to estrogen challenge test in women with and without premenstrual dysphoria. Psychoneuroendocrinology. 2006 May;31(4):415-27. doi: 10.1016/j.psyneuen.2005.10.004. PMID: 16359822. n = 25

  46. Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR (2000): Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry. 2000 Jun;157(6):924-30. doi: 10.1176/appi.ajp.157.6.924. PMID: 10831472. n = 16

  47. Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL (2006): Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry. 2006 Apr;63(4):385-90. doi: 10.1001/archpsyc.63.4.385. PMID: 16585467. n = 460

  48. Buchanan CM, Eccles JS, Becker JB (1992): Are adolescents the victims of raging hormones: evidence for activational effects of hormones on moods and behavior at adolescence. Psychol Bull. 1992 Jan;111(1):62-107. doi: 10.1037/0033-2909.111.1.62. PMID: 1539089. REVIEW

  49. Freeman EW, Sammel MD, Lin H, Nelson DB (2006): Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry. 2006 Apr;63(4):375-82. doi: 10.1001/archpsyc.63.4.375. PMID: 16585466.

  50. Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L (2004): Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry. 2004 Jan;61(1):62-70. doi: 10.1001/archpsyc.61.1.62. PMID: 14706945. n = 436

  51. [Freeman EW, Sammel MD, Lin H, Nelson DB (2006): Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry. 2006 Apr;63(4):375-82. doi: 10.1001/archpsyc.63.4.375. PMID: 16585466.](

  52. Zweifel JE, O’Brien WH (1997) A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology. 1997 Apr;22(3):189-212. doi: 10.1016/s0306-4530(96)00034-0. Erratum in: Psychoneuroendocrinology 1997 Nov;22(8):655. PMID: 9203229. METASTUDIE

  53. Rasgon NL, Dunkin J, Fairbanks L, Altshuler LL, Troung C, Elman S, Wroolie TE, Brunhuber MV, Rapkin A (2007): Estrogen and response to sertraline in postmenopausal women with major depressive disorder: a pilot study. J Psychiatr Res. 2007 Apr-Jun;41(3-4):338-43. doi: 10.1016/j.jpsychires.2006.03.009. PMID: 16697413.

  54. Galea LA, Wide JK, Barr AM (2001): Estradiol alleviates depressive-like symptoms in a novel animal model of post-partum depression. Behav Brain Res. 2001 Jul;122(1):1-9. doi: 10.1016/s0166-4328(01)00170-x. PMID: 11287071.

  55. Estrada-Camarena E, Fernández-Guasti A, López-Rubalcava C (2003): Antidepressant-like effect of different estrogenic compounds in the forced swimming test. Neuropsychopharmacology. 2003 May;28(5):830-8. doi: 10.1038/sj.npp.1300097. PMID: 12637949.

  56. Bekku N, Yoshimura H (2005): Animal model of menopausal depressive-like state in female mice: prolongation of immobility time in the forced swimming test following ovariectomy. Psychopharmacology (Berl). 2005 Dec;183(3):300-7. doi: 10.1007/s00213-005-0179-0. PMID: 16228195.

  57. Bertrand PP, Paranavitane UT, Chavez C, Gogos A, Jones M, van den Buuse M (2005): The effect of low estrogen state on serotonin transporter function in mouse hippocampus: a behavioral and electrochemical study. Brain Res. 2005 Dec 7;1064(1-2):10-20. doi: 10.1016/j.brainres.2005.10.018. PMID: 16298349.

  58. Cameron JL (2004): Interrelationships between hormones, behavior, and affect during adolescence: understanding hormonal, physical, and brain changes occurring in association with pubertal activation of the reproductive axis. Introduction to part III. Ann N Y Acad Sci. 2004 Jun;1021:110-23. doi: 10.1196/annals.1308.012. PMID: 15251880. REVIEW

  59. Cameron JL (2004): Interrelationships between hormones, behavior, and affect during adolescence: complex relationships exist between reproductive hormones, stress-related hormones, and the activity of neural systems that regulate behavioral affect. Comments on part III. Ann N Y Acad Sci. 2004 Jun;1021:134-42. doi: 10.1196/annals.1308.015. PMID: 15251882. REVIEW

  60. Shansky, Glavis-Bloom, Lerman, McRae, Benson, Miller, Cosand, Horvath, Arnsten (2004): Estrogen mediates sex differences in stress-induced prefrontal cortex dysfunction. Mol Psychiatry. 2004 May;9(5):531-8.

  61. Frye CA, Wawrzycki J (2003): Effect of prenatal stress and gonadal hormone condition on depressive behaviors of female and male rats. Horm Behav. 2003 Nov;44(4):319-26. doi: 10.1016/s0018-506x(03)00159-4. PMID: 14613726.

  62. Goldstein JM, Jerram M, Poldrack R, Ahern T, Kennedy DN, Seidman LJ, Makris N (2005): Hormonal cycle modulates arousal circuitry in women using functional magnetic resonance imaging. J Neurosci. 2005 Oct 5;25(40):9309-16. doi: 10.1523/JNEUROSCI.2239-05.2005. PMID: 16207891; PMCID: PMC6725775.

  63. Lindheim SR, Legro RS, Morris RS, Wong IL, Tran DQ, Vijod MA, Stanczyk FZ, Lobo RA (1994): The effect of progestins on behavioral stress responses in postmenopausal women. J Soc Gynecol Investig. 1994 Jan-Mar;1(1):79-83. doi: 10.1177/107155769400100116. PMID: 9419752. n = 14

  64. Walf AA, Frye CA (2005): Antianxiety and antidepressive behavior produced by physiological estradiol regimen may be modulated by hypothalamic-pituitary-adrenal axis activity. Neuropsychopharmacology. 2005 Jul;30(7):1288-301. doi: 10.1038/sj.npp.1300708. PMID: 15756306.

  65. Roca CA, Schmidt PJ, Altemus M, Deuster P, Danaceau MA, Putnam K, Rubinow DR (2003): Differential menstrual cycle regulation of hypothalamic-pituitary-adrenal axis in women with premenstrual syndrome and controls. J Clin Endocrinol Metab. 2003 Jul;88(7):3057-63. doi: 10.1210/jc.2002-021570. PMID: 12843143.

  66. Maleki, Bashirian, Soltanian, Jenabi, Farhadinasab (2021): Association between polycystic ovary syndrome and risk of attention-deficit/hyperactivity disorder in offspring: a meta-analysis. Clin Exp Pediatr. 2021 Apr 15. doi: 10.3345/cep.2021.00178. PMID: 33872487. METASTUDIE

  67. Dalgaard, Andersen, Jensen, Larsen, Find, Boye, Jensen, Bilenberg, Glintborg (2021): Maternal polycystic ovary syndrome and attention deficit hyperactivity disorder in offspring at 3 years of age: Odense Child Cohort. Acta Obstet Gynecol Scand. 2021 Sep 6. doi: 10.1111/aogs.14259. PMID: 34490610. n = 1.776 Mütter

  68. Hergüner S, Harmancı H, Toy H. Attention deficit-hyperactivity disorder symptoms in women with polycystic ovary syndrome. Int J Psychiatry Med. 2015;50(3):317-25. doi: 10.1177/0091217415610311. PMID: 26449924. n = 80

  69. Rizwan S, Manning JT, Brabin BJ (2007): Maternal smoking during pregnancy and possible effects of in utero testosterone: evidence from the 2D:4D finger length ratio. Early Hum Dev. 2007 Feb;83(2):87-90. doi: 10.1016/j.earlhumdev.2006.05.005. PMID: 16814493.


  71. Banerjee TD, Middleton F, Faraone SV: Environmental risk factors for attention-deficit hyperactivity disorder. Acta Pædiatrica 2007;96, 1269–74. Zitiert nach Philipsen, Heßlinger, Tebartz van Elst: AufmerksamkeitsdefizitHyperaktivitätsstörung im Erwachsenenalter – Diagnostik, Ätiologie und Therapie (ÜBERSICHTSARBEIT), Deutsches Ärzteblatt, Jg. 105, Heft 17, 25. April 2008, Seite 311 – 317, 313

  72. Schwenke, Fasching, Faschingbauer, Pretscher, Kehl, Peretz, Keller, Häberle, Eichler, Irlbauer-Müller, Dammer, Beckmann, Schneider (2018): Predicting attention deficit hyperactivity disorder using pregnancy and birth characteristics. Arch Gynecol Obstet. 2018 Sep 8. doi: 10.1007/s00404-018-4888-0.

  73. Wang, Hu, Chen, Xue, Du (2019): Prenatal Tobacco Exposure Modulated the Association of Genetic variants with Diagnosed ADHD and its symptom domain in children: A Community Based Case-Control Study. Sci Rep. 2019 Mar 12;9(1):4274. doi: 10.1038/s41598-019-40850-w.

  74. Zambrano-Sánchez, Martínez-Cortés, Poblano, Dehesa-Moreno, Vázquez-Urbano, Del Río-Carlos (2019): Maternal smoking during pregnancy and physiological anxiety in children with attention deficit hyperactivity disorder. Appl Neuropsychol Child. 2019 Jul 3:1-8. doi: 10.1080/21622965.2019.1632708.

  75. McCarthy, Zhang, Wilkes, Vaillancourt, Biederman, Bhide (2022): Nicotine and the developing brain: Insights from preclinical models. Pharmacol Biochem Behav. 2022 Feb 14:173355. doi: 10.1016/j.pbb.2022.173355. PMID: 35176350.

  76. Berger DF, Sagvolden T (1998): Sex differences in operant discrimination behaviour in an animal model of attention-deficit hyperactivity disorder. Behav Brain Res. 1998 Jul;94(1):73-82. doi: 10.1016/s0166-4328(97)00171-x. PMID: 9708841.

  77. King JA, Barkley RA, Delville Y, Ferris CF (2000): Early androgen treatment decreases cognitive function and catecholamine innervation in an animal model of ADHD. Behav Brain Res. 2000 Jan;107(1-2):35-43. doi: 10.1016/s0166-4328(99)00113-8. PMID: 10628728.

  78. Andersen SL, Teicher MH (2000): Sex differences in dopamine receptors and their relevance to ADHD. Neurosci Biobehav Rev. 2000 Jan;24(1):137-41. doi: 10.1016/s0149-7634(99)00044-5. PMID: 10654670.

  79. Bucci DJ, Hopkins ME, Keene CS, Sharma M, Orr LE (2008): Sex differences in learning and inhibition in spontaneously hypertensive rats. Behav Brain Res. 2008 Feb 11;187(1):27-32. doi: 10.1016/j.bbr.2007.08.022. PMID: 17904233; PMCID: PMC2213537.

  80. Bucci DJ, Hopkins ME, Nunez AA, Breedlove SM, Sisk CL, Nigg JT (2008): Effects of sex hormones on associative learning in spontaneously hypertensive rats. Physiol Behav. 2008 Feb 27;93(3):651-7. doi: 10.1016/j.physbeh.2007.11.005. PMID: 18054054; PMCID: PMC2323907.

  81. Li JS, Huang YC (2006): Early androgen treatment influences the pattern and amount of locomotion activity differently and sexually differentially in an animal model of ADHD. Behav Brain Res. 2006 Nov 25;175(1):176-82. doi: 10.1016/j.bbr.2006.08.020. PMID: 16979765.

  82. King JA, Kelly TA, Delville Y (2000): Adult levels of testosterone alter catecholamine innervation in an animal model of attention-deficit hyperactivity disorder. Neuropsychobiology. 2000;42(4):163-8. doi: 10.1159/000026687. PMID: 11096329.

  83. Seidman LJ, Biederman J, Monuteaux MC, Valera E, Doyle AE, Faraone SV (2005): Impact of gender and age on executive functioning: do girls and boys with and without attention deficit hyperactivity disorder differ neuropsychologically in preteen and teenage years? Dev Neuropsychol. 2005;27(1):79-105. doi: 10.1207/s15326942dn2701_4. PMID: 15737943.

  84. Castellanos FX, Marvasti FF, Ducharme JL, Walter JM, Israel ME, Krain A, Pavlovsky C, Hommer DW (2000): Executive function oculomotor tasks in girls with ADHD. J Am Acad Child Adolesc Psychiatry. 2000 May;39(5):644-50. doi: 10.1097/00004583-200005000-00019. PMID: 10802983.

  85. Rucklidge JJ, Tannock R (2002): Neuropsychological profiles of adolescents with ADHD: effects of reading difficulties and gender. J Child Psychol Psychiatry. 2002 Nov;43(8):988-1003. doi: 10.1111/1469-7610.00227. PMID: 12455921.

  86. Nigg JT, Blaskey LG, Huang-Pollock CL, Rappley MD (2002): Neuropsychological executive functions and DSM-IV ADHD subtypes. J Am Acad Child Adolesc Psychiatry. 2002 Jan;41(1):59-66. doi: 10.1097/00004583-200201000-00012. PMID: 11800208.

  87. Williams JH, Greenhalgh KD, Manning JT (2003): Second to fourth finger ratio and possible precursors of developmental psychopathology in preschool children. Early Hum Dev. 2003 May;72(1):57-65. doi: 10.1016/s0378-3782(03)00012-4. PMID: 12706312.

  88. Roberts BA, Martel MM (2013):. Prenatal Testosterone and Preschool Disruptive Behavior Disorders. Pers Individ Dif. 2013 Nov;55(8):962-966. doi: 10.1016/j.paid.2013.08.002. PMID: 25598567; PMCID: PMC4295489. n = 109

  89. Stevenson JC, Everson PM, Williams DC, Hipskind G, Grimes M, Mahoney ER (2007): Attention deficit/hyperactivity disorder (ADHD) symptoms and digit ratios in a college sample. Am J Hum Biol. 2007 Jan-Feb;19(1):41-50. doi: 10.1002/ajhb.20571. PMID: 17160985. n = 187

  90. Fink B, Manning J, Williams J, Podmore-Nappin C (2007): The 2nd to 4th digit ratio and developmental psychopathology in school-aged children. Personality and Individual Differences, Volume 42, Issue 2, January 2007, Pages 369-379. n = 58

  91. Bitsko RH, Holbrook JR, O’Masta B, Maher B, Cerles A, Saadeh K, Mahmooth Z, MacMillan LM, Rush M, Kaminski JW (2022): A Systematic Review and Meta-analysis of Prenatal, Birth, and Postnatal Factors Associated with Attention-Deficit/Hyperactivity Disorder in Children. Prev Sci. 2022 Mar 18:10.1007/s11121-022-01359-3. doi: 10.1007/s11121-022-01359-3. PMID: 35303250; PMCID: PMC9482663. REVIEW und METASTUDIE

  92. Akkuş M, Avşar PA (2024): 2D:4D ratio, alexithymia, impulsivity, aggression, and ADHD in men with opioid and methamphetamine use disorders: A comparative analysis with healthy controls. Early Hum Dev. 2024 Jan 22;189:105946. doi: 10.1016/j.earlhumdev.2024.105946. PMID: 38280313.

  93. Fink B, Neave N, Laughton K, Manning J (2006): Second to fourth digit ratio and sensation seeking. Personality and Individual Differences, Volume 41, Issue 7, November 2006, Pages 1253-1262

  94. Aluja A, Torrubia R ( 2004): Hostility-aggressiveness, sensation seeking, and sex hormones in men: re-exploring their relationship. Neuropsychobiology. 2004;50(1):102-7. doi: 10.1159/000077947. PMID: 15179027.

  95. Rosenblitt JC, Soler H, Johnson SE, Quadagno DM (2001): Sensation seeking and hormones in men and women: exploring the link. Horm Behav. 2001 Nov;40(3):396-402. doi: 10.1006/hbeh.2001.1704. PMID: 11673912.

  96. Martel MM, Gobrogge KL, Breedlove SM, Nigg JT (2008): Masculinized finger-length ratios of boys, but not girls, are associated with attention-deficit/hyperactivity disorder. Behav Neurosci. 2008 Apr;122(2):273-81. doi: 10.1037/0735-7044.122.2.273. PMID: 18410167; PMCID: PMC2902868., n = 58

  97. McFadden D, Westhafer G, Pasanen E, Carlson C, Tucker D (2005): Physiological evidence of hypermasculinization in boys with the inattentive type of attention-deficit/hyperactivity disorder (ADHD), Clinical Neuroscience Research, Volume 5, Issues 5–6, 2005, Pages 233-245, ISSN 1566-2772, n = 79

  98. Wernicke J, Zabel JT, Zhang Y, Becker B, Montag C (2020): Association between tendencies for attention-deficit/hyperactivity disorder (ADHD) and the 2D:4D digit ratio: a cross-cultural replication in Germany and China. Early Hum Dev. 2020 Apr;143:104943. doi: 10.1016/j.earlhumdev.2019.104943. PMID: 32126477. REVIEW, n = 192

  99. Lemiere J, Boets B (2010): Danckaerts M. No association between the 2D:4D fetal testosterone marker and multidimensional attentional abilities in children with ADHD. Dev Med Child Neurol. 2010 Sep;52(9):e202-8. doi: 10.1111/j.1469-8749.2010.03684.x. PMID: 20491856. N = 110

  100. Martel MM (2009): Conscientiousness as a mediator of the association between masculinized finger-length ratios and attention-deficit/hyperactivity disorder (ADHD). J Child Psychol Psychiatry. 2009 Jul;50(7):790-8. doi: 10.1111/j.1469-7610.2009.02065.x. PMID: 19298468; PMCID: PMC4311552. n = 312

  101. de Bruin EI, Verheij F, Wiegman T, Ferdinand RF (2006): Differences in finger length ratio between males with autism, pervasive developmental disorder-not otherwise specified, ADHD, and anxiety disorders. Dev Med Child Neurol. 2006 Dec;48(12):962-5. doi: 10.1017/S0012162206002118. PMID: 17109783. n = 240

  102. James WH (2008) Further evidence that some male-based neurodevelopmental disorders are associated with high intrauterine testosterone concentrations. Dev Med Child Neurol. 2008 Jan;50(1):15-8. doi: 10.1111/j.1469-8749.2007.02001.x. PMID: 18173623. METASTUDIE

  103. Ross JL, Stefanatos GA, Kushner H, Zinn A, Bondy C, Roeltgen D (2002): Persistent cognitive deficits in adult women with Turner syndrome. Neurology. 2002 Jan 22;58(2):218-25. doi: 10.1212/wnl.58.2.218. PMID: 11805247. n = 121

  104. Liben LS, Susman EJ, Finkelstein JW, Chinchilli VM, Kunselman S, Schwab J, Dubas JS, Demers LM, Lookingbill G, Darcangelo MR, Krogh HR, Kulin HE (2002): The effects of sex steroids on spatial performance: a review and an experimental clinical investigation. Dev Psychol. 2002 Mar;38(2):236-53. PMID: 11881759.

  105. Roberts B, Eisenlohr-Moul T, Martel MM (2018): Reproductive steroids and ADHD symptoms across the menstrual cycle. Psychoneuroendocrinology. 2018 Feb;88:105-114. doi: 10.1016/j.psyneuen.2017.11.015. PMID: 29197795; PMCID: PMC5803442.

  106. Ho, P., Garner, Ho, J., Leung, Chu, Kwok, Kung, Burka, Ramsden, Ho, S. (2008): Estrogenic Phenol and Catechol Metabolites of PCBs Modulate Catechol-Omethyltransferase Expression Via the Estrogen Receptor: Potential Contribution to Cancer Risk; Current Drug Metabolism, Volume 9, Number 4, May 2008, pp. 304-309(6); DOI:

  107. Lamb, McKay, Singh, Waldie, Kirk (2003): Catechol-O-methyltransferase val158met Polymorphism Interacts with Sex to Affect Face Recognition Ability; Front Psychol. 2016; 7: 965. doi: 10.3389/fpsyg.2016.00965; PMCID: PMC4921451

  108. Xie, Ho, Ramsden (1999): Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol Pharmacol. 1999 Jul;56(1):31-8.


  110. Boudíková, Szumlanski, Maidak, Weinshilboum (1990): Human liver catechol-O-methyltransferase pharmacogenetics. Clin Pharmacol Ther. 1990 Oct;48(4):381-9.

  111. Chen, Lipska, Halim, Ma, Matsumoto, Melhem, Kolachana, Hyde, Herman, Apud, Egan, Kleinman, Weinberger (2004): Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet. 2004 Nov;75(5):807-21.

  112. Karoum, Chrapusta, Egan (1994): 3-Methoxytyramine Is the Major Metabolite of Released Dopamine in the Rat Frontal Cortex: Reassessment of the Effects of Antipsychotics on the Dynamics of Dopamine Release and Metabolism in the Frontal Cortex, Nucleus Accumbens, and Striatum by a Simple Two Pool Model. Journal of Neurochemistry, 63: 972–979. doi:10.1046/j.1471-4159.1994.63030972.x

  113. Diamond (2014): Biologische und soziale Einflüsse auf kognitive Kontrollprozesse, die vom präfrontalen Kortex abhängen; In: Kubesch (Herausgeberin): Exekutive Funktionen und Selbstregulation – Neurowissenschaftliche Grundlagen und Transfer in die pädagogische Praxis; Huber, Seite 31


  115. Wood, Beylin, Shors (2001): The contribution of adrenal and reproductive hormones to the opposing effects of stress on trace conditioning in males versus females. Behav Neurosci. 2001 Feb;115(1):175-87.

  116. Shors, Leuner (2003): Estrogen-mediated effects on depression and memory formation in females. J Affect Disord. 2003 Mar;74(1):85-96.

  117. Arnsten, Cai, Murphy, Goldman-Rakic (1994): Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology (Berl). 1994 Oct;116(2):143-51.

  118. Shors (2001): Acute stress rapidly and persistently enhances memory formation in the male rat. Neurobiol Learn Mem. 2001 Jan;75(1):10-29.

  119. Wood, Shors (1998): Stress facilitates classical conditioning in males, but impairs classical conditioning in females through activational effects of ovarian hormones; Proc Natl Acad Sci U S A. 1998 Mar 31; 95(7): 4066–4071. PMCID: PMC19964

  120. Tops, Van Peer, Korf, Wijers, Tucker (2007): Anxiety, cortisol, and attachment predict plasma oxytocin. Psychophysiology, 44: 444-449. doi:10.1111/j.1469-8986.2007.00510.x

  121. Klein, Corwin (2002): Seeing the unexpected: how sex differences in stress responses may provide a new perspective on the manifestation of psychiatric disorders. Curr Psychiatry Rep. 2002 Dec;4(6):441-8.

  122. Iqbal J, Huang GD, Xue YX, Yang M, Jia XJ (2024): Role of estrogen in sex differences in memory, emotion and neuropsychiatric disorders. Mol Biol Rep. 2024 Mar 12;51(1):415. doi: 10.1007/s11033-024-09374-z. PMID: 38472517. REVIEW

  123. Gershon J (2002): A meta-analytic review of gender differences in ADHD. J Atten Disord. 2002 Jan;5(3):143-54. doi: 10.1177/108705470200500302. PMID: 11911007. METASTUDY

  124. Skogli, Teicher, Andersen, Hovik, Merete (2013): ADHD in girls and boys – gender differences in co-existing symptoms and executive function measures; BMC Psychiatry 2013, 13:298;

  125. Murray, Booth, Eisner, Auyeung, Murray, Ribeaud (2018): Sex differences in ADHD trajectories across childhood and adolescence. Dev Sci. 2018 Aug 29:e12721. doi: 10.1111/desc.12721.

  126. Lundström, Mårland, Kuja-Halkola, Anckarsäter, Lichtenstein, Gillberg, Nilsson (2019): Assessing autism in females: The importance of a sex-specific comparison. Psychiatry Res. 2019 Sep 13:112566. doi: 10.1016/j.psychres.2019.112566. n = 30,392

  127. Hayashi, Suzuki, Saga, Arai, Igarashi, Tokumasu, Ota, Yamada, Takashio, Iwanami (2019): Clinical Characteristics of Women with ADHD in Japan. Neuropsychiatr Dis Treat. 2019 Dec 4;15:3367-3374. doi: 10.2147/NDT.S232565. eCollection 2019.

  128. Mahendiran, Brian, Dupuis, Muhe, Wong, Iaboni, Anagnostou (2019): Meta-Analysis of Sex Differences in Social and Communication Function in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder. Front Psychiatry. 2019 Nov 4;10:804. doi: 10.3389/fpsyt.2019.00804. eCollection 2019.

  129. Papaleo, Crawley, Song, Lipska, Pickel, Weinberger, Chen (2008): Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice. J Neurosci. 2008 Aug 27;28(35):8709-23. doi: 10.1523/JNEUROSCI.2077-08.2008.

  130. Nackley, Shabalina, Tchivileva, Satterfield, Korchynskyi, Makarov, Maixner, Diatchenko (2006): Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science. 2006 Dec 22;314(5807):1930-3.

  131. Diamond (2014): Biologische und soziale Einflüsse auf kognitive Kontrollprozesse, die vom präfrontalen Kortex abhängen; In: Kubesch (Herausgeberin): Exekutive Funktionen und Selbstregulation – Neurowissenschaftliche Grundlagen und Transfer in die pädagogische Praxis; Huber, Seite 28

  132. Egan, Goldberg, Kolachana, Callicott, Mazzanti, Straub, Goldman, Weinberger (20019): Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6917-22.

  133. Mattay, Goldberg, Fera, Hariri, Tessitore, Egan, Kolachana, Callicott, Weinberger (2003): Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A. 2003 May 13;100(10):6186-91.

  134. Evans, Fossella, Hampson, Kirschbaum, Diamond (2009): Gender Differences in the Cognitive Functions Sensitive to the Level of Dopamine in Prefrontal Cortex. n = 30

  135. Quinn, Madhoo (2014): A Review of Attention-Deficit/Hyperactivity Disorder in Women and Girls: Uncovering This Hidden Diagnosis; Prim Care Companion CNS Disord. 2014; 16(3): PCC.13r01596. PMCID: PMC4195638; PMID: 25317366

  136. Endres, Tebartz van Elst, Maier, Feige, Goll, Meyer, Matthies, Domschke, Lange, Sobanski, Philipsen, Nickel, Perlov (2019): Neurochemical sex differences in adult ADHD patients: an MRS study. Biol Sex Differ. 2019 Oct 29;10(1):50. doi: 10.1186/s13293-019-0264-4.

  137. Kok FM, Groen Y, Fuermaier ABM, Tucha O (2020): The female side of pharmacotherapy for ADHD-A systematic literature review. PLoS One. 2020 Sep 18;15(9):e0239257. doi: 10.1371/journal.pone.0239257. PMID: 32946507; PMCID: PMC7500607. METASTUDY

Diese Seite wurde am 20.05.2024 zuletzt aktualisiert.